PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer SpyBiotech
14-Aug-2024 Breakthrough heart MRI technique accurately predicts heart failure risk in general population The University of East Anglia (UEA)
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026 Santhera Pharmaceuticals
14-Aug-2024 New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease
14-Aug-2024 PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors PureTech Health plc
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
14-Aug-2024 ViroCell Biologics completes oversubscribed financing ViroCell Biologics
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics
09-Aug-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024 Nxera Pharma
07-Aug-2024 CLINIGEN ACQUIRES KINESYS CONSULTING TO BOLSTER REGULATORY AFFAIRS EXPERTISE Clinigen
07-Aug-2024 XF-73 treatment of MRSA burn wound infection prevents bacterial invasion of the bloodstream Destiny Pharma plc
07-Aug-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
07-Aug-2024 New results from AlzeCure's pain project TrkA-NAM presented at the pain conference IASP 2024 AlzeCure Pharma AB
07-Aug-2024 Release Therapeutics Secures CHF 3.3 Million in Seed Funding Release Therapeutics
07-Aug-2024 Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K. Velocity Clinical Research
07-Aug-2024 Kyowa Kirin International and NewBridge Pharmaceuticals enter into agreement to improve access to medicines for rare disease patients across Middle East and North Africa Kyowa Kirin International
07-Aug-2024 Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials Lindus Health
06-Aug-2024 Adoption of ICH E6 (R3) is Coming Pharma Lessons